Cantor Fitzgerald Comments on Humana FY2025 Earnings

Humana Inc. (NYSE:HUM - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Humana in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst S. James forecasts that the insurance provider will earn $16.17 per share for the year. Cantor Fitzgerald has a "Neutral" rating and a $395.00 price target on the stock. The consensus estimate for Humana's current full-year earnings is $16.11 per share.

Other research analysts also recently issued research reports about the stock. Wells Fargo & Company dropped their price objective on shares of Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a report on Monday, November 4th. Morgan Stanley increased their price target on shares of Humana from $288.00 to $301.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Leerink Partnrs downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a report on Wednesday, October 2nd. UBS Group lowered their price target on shares of Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, October 4th. Finally, Sanford C. Bernstein raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a research report on Tuesday, October 8th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Humana presently has an average rating of "Hold" and an average target price of $302.80.

Humana Price Performance

Humana stock traded up $0.74 during mid-day trading on Wednesday, hitting $285.41. The stock had a trading volume of 520,748 shares, compared to its average volume of 1,283,561. The firm has a market capitalization of $34.37 billion, a P/E ratio of 25.29, a P/E/G ratio of 2.13 and a beta of 0.55. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm's 50 day moving average is $273.91 and its 200 day moving average is $306.03. Humana has a one year low of $213.31 and a one year high of $411.80.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.24%. Humana's dividend payout ratio (DPR) is 31.36%.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.29% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently modified their holdings of the company. CKW Financial Group boosted its position in shares of Humana by 90.9% during the 4th quarter. CKW Financial Group now owns 525 shares of the insurance provider's stock valued at $133,000 after purchasing an additional 250 shares in the last quarter. Pacer Advisors Inc. raised its position in Humana by 58.5% during the fourth quarter. Pacer Advisors Inc. now owns 15,579 shares of the insurance provider's stock valued at $3,953,000 after acquiring an additional 5,750 shares in the last quarter. KBC Group NV raised its position in Humana by 26.0% during the fourth quarter. KBC Group NV now owns 48,685 shares of the insurance provider's stock valued at $12,352,000 after acquiring an additional 10,039 shares in the last quarter. Blue Trust Inc. raised its position in Humana by 15.3% during the fourth quarter. Blue Trust Inc. now owns 1,692 shares of the insurance provider's stock valued at $429,000 after acquiring an additional 224 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC raised its position in Humana by 23.0% during the fourth quarter. Kingswood Wealth Advisors LLC now owns 9,379 shares of the insurance provider's stock valued at $2,380,000 after acquiring an additional 1,751 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.